ArriVent BioPharma, Inc.

ArriVent BioPharma, Inc. financial statements

ArriVent BioPharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

Net income−USD 166.31M10-K
Cash and equivalentsUSD 45.54M10-Q

ArriVent BioPharma, Inc. financials on 6ix · ArriVent BioPharma, Inc. on 6ix